These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35363213)

  • 1. Efficacy and safety of rt-PA intravenous thrombolysis in patients with wake-up stroke: A meta-analysis.
    Liu H; Hu W; Zhang F; Gu W; Hong J; Chen J; Huang Y; Pan H
    Medicine (Baltimore); 2022 Feb; 101(7):e28914. PubMed ID: 35363213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis for Wake-Up Stroke Versus Non-Wake-Up Unwitnessed Stroke: EOS Individual Patient Data Meta-Analysis.
    Kamogawa N; Miwa K; Toyoda K; Jensen M; Inoue M; Yoshimura S; Fukuda-Doi M; Kitazono T; Boutitie F; Ma H; Ringleb P; Wu O; Schwamm LH; Warach S; Hacke W; Davis SM; Donnan GA; Gerloff C; Thomalla G; Koga M;
    Stroke; 2024 Apr; 55(4):895-904. PubMed ID: 38456303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolytic therapy for patients who wake-up with stroke.
    Barreto AD; Martin-Schild S; Hallevi H; Morales MM; Abraham AT; Gonzales NR; Illoh K; Grotta JC; Savitz SI
    Stroke; 2009 Mar; 40(3):827-32. PubMed ID: 19131657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic Treatment in Wake-Up Stroke: A Propensity Score-Matched Analysis of Treatment Effectiveness in the Norwegian Stroke Registry.
    Søyland MH; Tveiten A; Eltoft A; Øygarden H; Varmdal T; Indredavik B; Mathiesen EB
    J Am Heart Assoc; 2024 Feb; 13(3):e032309. PubMed ID: 38293909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
    Guo C; Bai Q; Zhao Z; Zhang J
    Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic therapy for wake-up stroke: A systematic review and meta-analysis.
    Mac Grory B; Saldanha IJ; Mistry EA; Stretz C; Poli S; Sykora M; Kellert L; Feil K; Shah S; McTaggart R; Riebau D; Yaghi S; Gaines K; Xian Y; Feng W; Schrag M
    Eur J Neurol; 2021 Jun; 28(6):2006-2016. PubMed ID: 33772987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.
    Lei YS; Li H; Lei JY; Li SX; Li DF
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):779-786. PubMed ID: 35179744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese herbal injections combined with rt-PA intravenous thrombolysis for acute ischemic stroke: A systematic review and meta-analysis protocol.
    Wu J; Wang L; Dong X; Li Z; Wang K; Li L; Liu J
    Medicine (Baltimore); 2021 Mar; 100(10):e25004. PubMed ID: 33725879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and effectiveness of early anti-platelet therapy after alteplase for acute ischemic stroke: A meta-analysis.
    Liu J; Hu X; Wang Y; Guan X; Chen J; Liu H
    J Clin Neurosci; 2021 Sep; 91():176-182. PubMed ID: 34373024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reperfusion therapy for minor stroke: A systematic review and meta-analysis.
    Lan L; Rong X; Li X; Zhang X; Pan J; Wang H; Shen Q; Peng Y
    Brain Behav; 2019 Oct; 9(10):e01398. PubMed ID: 31532082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
    Sørensen SB; Barazangi N; Chen C; Wong C; Grosvenor D; Rose J; Bedenk A; Morrow M; McDermott D; Hove JD; Tong DC
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of a new modified intravenous recombinant tissue plasminogen activator (rt-PA) regimen in Chinese patients with acute ischemic stroke: A descriptive retrospective cohort study with subgroup-analysis of different rt-PA dose.
    Luo Y; Li J; Huang L; Liu X; Zhang B; Lin J; Jiang A; Zhao J
    J Clin Neurosci; 2022 Jul; 101():244-251. PubMed ID: 35653882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed tomography perfusion-based thrombolysis in wake-up stroke.
    Morelli N; Rota E; Immovilli P; Cosottini M; Giorgi-Pierfranceschi M; Magnacavallo A; Michieletti E; Morelli J; Guidetti D
    Intern Emerg Med; 2015 Dec; 10(8):977-84. PubMed ID: 26370239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial.
    Pancioli AM; Adeoye O; Schmit PA; Khoury J; Levine SR; Tomsick TA; Sucharew H; Brooks CE; Crocco TJ; Gutmann L; Hemmen TM; Kasner SE; Kleindorfer D; Knight WA; Martini S; McKinney JS; Meurer WJ; Meyer BC; Schneider A; Scott PA; Starkman S; Warach S; Broderick JP;
    Stroke; 2013 Sep; 44(9):2381-7. PubMed ID: 23887841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
    Fan Y; Liao X; Pan Y; Dong K; Wang Y; Wang Y;
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-contrast head CT-based thrombolysis for wake-up/unknown onset stroke is safe: A single-center study and meta-analysis.
    Zha AM; Kamal H; Jeevarajan JA; Arevalo O; Zhu L; Ankrom CM; Bonfante-Mejia EE; Cossey TD; Wu TC; Barreto AD; Grotta JC; Jagolino-Cole AL
    Int J Stroke; 2022 Mar; 17(3):354-361. PubMed ID: 33724081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoprotein level is associated with hemorrhage transformation after ischemic stroke treatment with intravenous thrombolysis: A systematic review and meta-analysis.
    Zhang W; Li W; Tian R; Cao L
    J Clin Neurosci; 2022 Dec; 106():122-127. PubMed ID: 36283344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.